Wohl Petr, Wohl Pavel, Girman Peter, Pelikánová Terezie
Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Metabolism. 2004 May;53(5):655-9. doi: 10.1016/j.metabol.2003.12.013.
Obese, insulin-resistant patients have been shown to have metabolic inflexibility. The goal of this study was to examine the effect of insulin administration on energy metabolism in lean, type 1 diabetic (DM1) patients. Eleven DM1 patients without vascular complications and 11 healthy controls (C) were examined. We performed a 2-step hyperinsulinemic euglycemic clamp (240 minutes; period 1: 1 mU. kg(-1). min(-1) and period 2: 10 mU. kg(-1). min(-1)) combined with indirect calorimetry during basal period B (B, -45 to 0 minutes), period 1, and period 2 of the clamp. The metabolic clearance rates of glucose (MCR) were lower in DM1 compared with C in period 1 (12.54 +/- 3.38 v 17.41 +/- 6.18 mL. kg(-1). min(-1); P <.02), as well as in period 2 (21.63 +/- 6.47 v 26.61 +/- 4.45 mL. kg(-1). min(-1); P <.05). Basal respiratory quotient (RQ) was lower in DM1 compared with C (0.72 +/- 0.04 v 0.75 +/- 0.04; P <.03). Insulin administration was accompanied by an increase in RQ in both groups, which was lower in DM1 compared with C (period 1: +0.09 +/- 0.04 v +0.11 +/- 0.07; P <.001; period 2: +0.13 +/- 0.04 v +0.16 +/- 0.04; P <.001). Glucose oxidation did not differ between the groups in period B; however, it was lower in DM1 compared with C in periods 1 (1.17 +/- 0.67 v 3.28 +/- 1.11 mg. kg(-1). min(-1); P <.003); and 2 (2.10 +/- 0.64 v 3.28 +/- 0.93 mg. kg(-1). min(-1); P <.009). Lipid oxidation was higher in DM1 in all periods compared with C; period B (3.28 +/- 0.77 v 1.16 +/- 0.55 mg. kg(-1). min(-1); P <.001), period 1 (1.10 +/- 0.41 v 0.67 +/- 0.54 mg. kg(-1). min(-1); P <.05), and period 2 (0.99 +/- 0.29 v 0.52 +/- 0.58 mg. kg(-1). min(-1); P <.01). The groups did not differ in protein oxidation. In conclusion, DM1 patients with secondary insulin resistance (IR) are characterized by metabolic inflexibility manifesting itself by smaller increases in RQ and glucose oxidation after insulin administration during the euglycemic clamp.
肥胖的胰岛素抵抗患者已被证明存在代谢灵活性受损的情况。本研究的目的是检验胰岛素给药对瘦型1型糖尿病(DM1)患者能量代谢的影响。对11例无血管并发症的DM1患者和11例健康对照者(C)进行了检查。我们进行了两步高胰岛素正常血糖钳夹试验(240分钟;第1阶段:1 mU·kg⁻¹·min⁻¹,第2阶段:10 mU·kg⁻¹·min⁻¹),并在钳夹的基础期B(B,-45至0分钟)、第1阶段和第2阶段结合间接测热法。在第1阶段(12.54±3.38对17.41±6.18 mL·kg⁻¹·min⁻¹;P<.02)以及第2阶段(21.63±6.47对26.61±4.45 mL·kg⁻¹·min⁻¹;P<.05),DM1患者的葡萄糖代谢清除率(MCR)低于C组。DM1患者的基础呼吸商(RQ)低于C组(0.72±0.04对0.75±0.04;P<.03)。两组胰岛素给药后RQ均升高,且DM1患者低于C组(第1阶段:+0.09±0.04对+0.11±0.07;P<.001;第2阶段:+0.13±0.04对+0.16±0.04;P<.001)。在基础期B,两组的葡萄糖氧化无差异;然而,在第1阶段(1.17±0.67对3.28±1.11 mg·kg⁻¹·min⁻¹;P<.003)和第2阶段(2.10±0.64对3.28±0.93 mg·kg⁻¹·min⁻¹;P<.009),DM1患者的葡萄糖氧化低于C组。在所有阶段,DM1患者的脂质氧化均高于C组;基础期B(3.28±0.77对1.16±0.55 mg·kg⁻¹·min⁻¹;P<.